This funding opportunity supports meritorious research proposals that critically and systematically evaluate scientific evidence on carcinogenic hazards to humans. The goal is to identify potential carcinogens to guide and advance cancer research and inform cancer control and prevention efforts. Clinical trials are not allowed under this R01 mechanism.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofit organizations, for-profit organizations including small businesses, and Native American tribal governments and organizations. Foreign organizations are eligible to apply, but foreign components
